Policy Name Effective Date Revision Date Next Review Date
D
mp-026 Drug Levels and Antibody Testing for Infliximab, Adalimumab, Vedolizumab and Ustekinumab September 20, 2021 July 15, 2021 July 15, 2022
H
MP-055 Homocysteine Level Testing September 26, 2021 July 26, 2021 July 26, 2022
S
MP-069 Serologic Testing for Liver Fibrosis April 23, 2022 February 23, 2022 February 23, 2023
V
MP-056 Vitamin D Testing June 16, 2021 June 16, 2021 June 16, 2022
To Top